CollPlant Biotechnologies Ltd.
CLGN · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Revenue | $77 | $179 | $2,055 | $164 |
| % Growth | -57% | -91.3% | 1,153% | – |
| Cost of Goods Sold | $492 | $415 | $432 | $514 |
| Gross Profit | -$415 | -$236 | $1,623 | -$350 |
| % Margin | -539% | -131.8% | 79% | -213.4% |
| R&D Expenses | $2,089 | $2,013 | $2,105 | $2,543 |
| G&A Expenses | $0 | $0 | $0 | $0 |
| SG&A Expenses | $1,003 | $929 | $1,166 | $1,081 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | $0 |
| Operating Expenses | $3,092 | $2,942 | $3,271 | $3,624 |
| Operating Income | -$3,507 | -$3,178 | -$1,648 | -$3,974 |
| % Margin | -4,554.5% | -1,775.4% | -80.2% | -2,423.2% |
| Other Income/Exp. Net | $24 | -$169 | $196 | $96 |
| Pre-Tax Income | -$3,483 | -$3,347 | -$1,452 | -$3,878 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$3,483 | -$3,347 | -$1,452 | -$3,878 |
| % Margin | -4,523.4% | -1,869.8% | -70.7% | -2,364.6% |
| EPS | -0.27 | -0.28 | -0.13 | -0.34 |
| % Growth | 3.6% | -115.4% | 61.8% | – |
| EPS Diluted | -0.27 | -0.28 | -0.13 | -0.34 |
| Weighted Avg Shares Out | 12,722 | 11,841 | 11,455 | 11,455 |
| Weighted Avg Shares Out Dil | 12,722 | 11,841 | 11,455 | 11,455 |
| Supplemental Information | – | – | – | – |
| Interest Income | $24 | $0 | $196 | $96 |
| Interest Expense | $0 | $169 | $0 | $0 |
| Depreciation & Amortization | $223 | $229 | $244 | $242 |
| EBITDA | -$3,260 | -$2,949 | -$1,208 | -$3,636 |
| % Margin | -4,233.8% | -1,647.5% | -58.8% | -2,217.1% |